Target Name: SHLD1
NCBI ID: G149840
Review Report on SHLD1 Target / Biomarker Content of Review Report on SHLD1 Target / Biomarker
SHLD1
Other Name(s): shieldin complex subunit 1 | C20orf196 | SHLD1 variant 2 | Shield complex subunit 1 | uncharacterized protein C20orf196 | RP4-784N16.1 | Uncharacterized protein C20orf196 | Shieldin complex subunit 1 (isoform 1) | Shieldin complex subunit 1 | shield complex subunit 1 | RINN1-REV7-interacting novel NHEJ regulator 3 | RINN3 | Shieldin complex subunit 1, transcript variant 2 | SHLD1_HUMAN

SHLD1: A Potential Drug Target and Biomarker

Shieldin complex subunit 1 (SHLD1) is a protein that plays a critical role in the development and maintenance of tissues, particularly the nervous system. It is a member of the shieldin complex, which is a protein complex involved in the regulation of cellular processes such as cell growth, differentiation, and survival. The shieldin complex is composed of several subunits, including SHLD1, which is essential for its proper function.

Recent studies have identified SHLD1 as a potential drug target and biomarker for a variety of diseases, including neurodegenerative disorders, cancer, and autoimmune diseases. This is due to SHLD1's involvement in several cellular processes that are disrupted in these diseases, as well as its unique structure and expression pattern.

One of the main functions of SHLD1 is its role in the regulation of cell growth and differentiation. SHLD1 helps to ensure that cells maintain a proper size and shape, and that they do not undergo rapid growth or uncontrolled division. This is important for the development and maintenance of tissues, as well as for the prevention of cancer.

In addition to its role in cell growth and differentiation, SHLD1 is also involved in the regulation of cell survival. It has been shown to play a role in the regulation of cell survival and apoptosis, which is the process by which cells undergo programmed cell death. This is important for the regulation of cellular aging and the prevention of age-related diseases.

The shieldin complex is also involved in the regulation of cell-cell interactions and tissue architecture. SHLD1 helps to ensure that cells stick to each other and form tissues, and that they do not detach or migrate away from their proper locations. This is important for the development and maintenance of tissues and organs, as well as for the regulation of normal physiological processes.

In conclusion, SHLD1 is a protein that plays a critical role in several cellular processes that are important for the development and maintenance of tissues and organs. Its involvement in cell growth, differentiation, and survival, as well as its unique structure and expression pattern, make it an attractive target for drug development and research into the underlying causes of various diseases. Further studies are needed to fully understand the role of SHLD1 in these processes and to develop effective treatments for SHLD1-related diseases.

Protein Name: Shieldin Complex Subunit 1

Functions: Component of the shieldin complex, which plays an important role in repair of DNA double-stranded breaks (DSBs). During G1 and S phase of the cell cycle, the complex functions downstream of TP53BP1 to promote non-homologous end joining (NHEJ) and suppress DNA end resection. Mediates various NHEJ-dependent processes including immunoglobulin class-switch recombination, and fusion of unprotected telomeres

The "SHLD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SHLD1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SHLD2 | SHLD2P1 | SHLD2P3 | SHLD3 | SHMT1 | SHMT2 | SHOC1 | SHOC2 | Short transient receptor potential channel (TrpC) | SHOX | SHOX2 | SHPK | SHPRH | SHQ1 | SHROOM1 | SHROOM2 | SHROOM3 | SHROOM4 | SHTN1 | SI | SIAE | SIAH1 | SIAH2 | SIAH3 | Sialidase | Sialyltransferase | SIDT1 | SIDT2 | SIGIRR | SIGLEC1 | SIGLEC10 | SIGLEC11 | SIGLEC12 | SIGLEC14 | SIGLEC15 | SIGLEC16 | SIGLEC17P | SIGLEC5 | SIGLEC6 | SIGLEC7 | SIGLEC8 | SIGLEC9 | SIGLECL1 | sigma Receptor | SIGMAR1 | Signal peptidase complex | Signal recognition particle | Signal recognition particle receptor | Signal Transducers and Activators of Transcription (STAT) | SIK1 | SIK2 | SIK3 | SIKE1 | SIL1 | SILC1 | SIM1 | SIM2 | SIMC1 | SIN3 complex | SIN3A | SIN3B | SINHCAF | SIPA1 | SIPA1L1 | SIPA1L1-AS1 | SIPA1L2 | SIPA1L3 | SIRPA | SIRPAP1 | SIRPB1 | SIRPB2 | SIRPB3P | SIRPD | SIRPG | SIRPG-AS1 | SIRT1 | SIRT2 | SIRT3 | SIRT4 | SIRT5 | SIRT6 | SIRT7 | SIT1 | SIVA1 | SIX1 | SIX2 | SIX3 | SIX3-AS1 | SIX4 | SIX5 | SIX6 | SKA1 | SKA1 complex | SKA2 | SKA2P1 | SKA3 | SKAP1 | SKAP1-AS2 | SKAP2 | Skeletal muscle troponin